Georgia Institute of Technology

Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery.

When one or more coronavirus vaccines receives FDA emergency use authorization, it will launch a major public health and logistics initiative.

Entrepreneur and Professor Raghupathy “Siva” Sivakumar has been named Georgia Tech’s inaugural Interim Chief Commercialization Officer. 

Flexible large-area organic photodiodes can now compete in performance with conventional silicon photodiode technology.

Georgia Tech and Pacific Northwest National Laboratory will expand interactions, collaborations and joint scientific output.